FIFTH COMMUNITY PHARMACY AGREEMENT: OVERVIEW OF STAKEHOLDER CONSULTATION ACTIVITIES TO
30 JUNE 2014
5CPA component / Consultation activity / With whom / Timeframe / Action taken in response /5CPA programmes / · Consumer views on the services and advice provided by pharmacies to consumers;
· The location of pharmacies;
· Issues relevant to competition between pharmacies; and
· Increased accountability of pharmacy owners for the professional pharmacy services provided to consumers. / · CHF / December 2009 – December 2010 / · Advice provided informed policy options and negotiations for 5CPA.
Medication Use Reviews (MedsCheck) and Diabetes Medication Management Service (Diabetes MedsCheck) / Advice sought on patient eligibility for the MedsCheck and Diabetes MedsCheck pilots / · PRG / December 2010 – June 2012 / · Inclusion of ‘improved adherence’ to the aims of the programme.
· Use of broad patient eligibility criteria initially for the pilot that could be refined to inform the national roll-out.
· Added ‘significant medical event and complexity/type of administration’ as an additional indicator to number of drugs included.
· The interim evaluation report was provided to the PRG on 1 February 2012 for comment. Further consultation may be undertaken following finalisation of the evaluation in
April 2012.
Two stage testing functionality of the Assessment Tool / · PSA
· AACP
· Guild
· Practising Community Pharmacists / June 2011 and July 2011 / · Feedback incorporated into Assessment Tool.
Consultation on community pharmacy software requirements / · MSIA / Finalised mid 2012 / · Developing vendor resource documents to inform possible open source software solutions linking dispense and claiming functions of the planned system.
Home Medicines Review (HMR) / Development of new direct referral pathway to HMR / · PSA
· Guild
· AACP
· Other stakeholder consultations under 4CPA HMR research project / December 2008 – October 2011 / · Implementation of a new direct referral pathway to HMR from 1 October 2011.
· Update of existing professional practice guidelines to incorporate the new referral pathway by PSA.
Home Medicines Review (HMR) / Development a hospital referral pathway for HMRs.
HMR hospital referral pathway stakeholder consultation workshop 29June 2012 / · PRG
· Guild
· AACP
· State and Territory health departments
· RACP
· APHA
· ACSQHC
· SHPA
· AGPN
· Public consultation / December 2008 – Ongoing / · A consultation paper was released on 9December 2011 and submissions closed on 20 January 2012. This paper was developed with input from PRG, and 75 submissions were received.
· Summary of the consultation responses provided to PRG for information on
19 April 2012.
· Further stakeholder consultations will be undertaken prior to finalisation of a HMR Hospital Referral Pathway.
· . Two hospitals selected (in Hobart and Melbourne) with the Department ready to commence, pending agreement on a commencement date with the Guild. A staggered national implementation is planned, which will be informed by data from the two initial sites.
HMR (and other MMR programmes) changes / · PRG / April 2013- ongoing / · Provide advice to inform options to restructure the HMR (and other MMR Programmes fee structure) to support programme sustainability and integrity.
HMR research project to collate and assess evidence in order to recommend better targeting of HMR patient eligibility criteria / · SHPA
· PSA
· Guild
· PRG / March 2013 – ongoing / · Joint involvement in development of RFT
· Ongoing input into project outcomes.
Residential Medication Management Review (RMMR) / Development of requirement for RMMR services to be collaborative (referred by a general practitioner) / · PSA
· Guild
· Other stakeholder consultations under 4CPA RMMR research project / May 2010 – October 2011 / · The change to require all reviews to be collaborative was implemented on 1October2011.
Development of policy changes to separate RMMR services from Quality Use of Medicines services.
PRG members asked to seek views from their members/organisations regarding unforeseen impacts from 1October 2011 changes to RMMR programme / · PSA
· Guild
· Other stakeholder consultations under 4CPA RMMR research project
· PRG / May 2010 – October 2011
August 2012 / · Splitting payments for RMMR and QUM services from 1 October 2011.
· Update of the existing professional practice guidelines to incorporate changes to the RMMR programme.
· Provide feedback as it arises.
Rural Pharmacy Workforce / Eligibility changes to a number of elements of RPWP resulting from PhARIA update and restrictions to PhARIA 2-6 / · ARHEN
· PSA
· Guild
· Pharmacy academics from various universities / 2011 – Ongoing / · Consultation with AHREN, PSA and PRG undertaken.
· Changes resulting from update to PhARIA classification implemented in July 2012.
· Exceptional circumstance criteria under development by Guild for
1) Rural and Remote Continuing Education Allowance
2) Rural Intern Training Allowance
3) Intern Incentive Allowance for Rural Pharmacies.
4) Rural Student Placement Allowance.
Advice on programme implementation, transitional arrangements and exceptions for the Rural Pharmacy Continuing Professional Education Allowance and the Rural Pharmacy Student Placement Allowance / · PRG / December 2011 – January 2012 / · Consultation undertaken over mid 2011 - January 2012.
· Advice provided to PRG on 19 April 2012 regarding changes to RPWP.
Rural Pharmacy Maintenance Allowance / Development of an updated model, in the context of a changing rural index / · Guild
· DHS
· University of Adelaide / Late 2010 – July 2012 / · Implementation complete and pharmacy owners advised where RPMA eligibility has not continued.
· An exceptional circumstance process is being managed by the Guild.
Section 100 Support Allowances to Remote Area Aboriginal Health Services (AHS) / Consultation on potential changes to programme arrangements / · PRG
· Guild
· Other stakeholder consultations under 4CPA evaluation of Indigenous pharmacy programmes
· Over 250 attendees at the Indigenous Joint Forum / 2010-11 –
Ongoing / · Indigenous Joint Forum held in Melbourne on 26/27 March 2012 provided opportunities for further consultation with all delegates (over 250 delegates attended).
· Joint Forum outcomes have been collated, consolidated and considered by QUMAX Reference Group and the 5CPA PRG. No final decisions regarding programme changes have been made.
Consultation on the recommendations from the Senate inquiry into the supply arrangements of PBS medicines to remote area AHSs (which included consideration of support arrangements) / · PRG / November 2011 - ongoing / · Government is in the process of finalising its response to the Senate inquiry recommendations.
QUM Framework to support rural and urban Aboriginal Health Services / Consultation on potential changes to programme arrangements / · PRG
· Guild
· Other stakeholder consultations under 4CPA evaluation of QUMAX programme
Over 250 attendees at the Indigenous Joint Forum / 2010-11 –
Ongoing / · Updated programme arrangements have been implemented.
· Indigenous Joint Forum held in Melbourne on 26/27 March 2012 provided opportunities for further consultation with all delegates (over 250 delegates attended).
· Joint Forum outcomes have been collated, consolidated and considered by QUMAX Reference Group and the 5CPA PRG.
Taking into account the findings from the 4CPA evaluation of QUMAX, consultation on changes to the QUMAX programme / QUMAX Programme Reference Group, made up of:
· DoHA
· Guild
· NACCHO
· PSA / Ongoing / · The new QUMAX programme model has been developed in the context of input from all stakeholders and implemented.
· QRG met on 14 February 2012 and
8 March 2012 to discuss QUMSP and NACCHO State Affiliate support arrangements post
30 June 2012.
· QRG met on 22 June 2012 – QUMSP and NACCHO State Affiliate support arrangements extended to 31 December 2012.
· From 1 Jan 2013, online education and training resources are being implemented to assist participating Aboriginal Health Services with their application, workplan and reporting requirements. Further assistance will also be available through Guild and NACCHO telephone hotlines.
Pharmacy Practice Incentive (PPI) and Accreditation
· PPI: Clinical Interventions by Pharmacists / Consultation regarding priorities for programme funding under 5CPA / Broad stakeholder input through PPSAC 4CPA Research & Development Steering Committee and 4CPA Research & Development project (PROMISe). / October 2008 – May 2010 / · Inclusion of Clinical Interventions as a priority programme area in 5CPA.
Activities to support the roll-out of the PPI Programme under 5CPA / PSA, with Expert Reference Group involvement, including Guild, SHPA, APESMA, ACP, APC, AACP, PDL, CHF, RACGP, AGPN, AMA, NPS, Carers Aust, ASMI / September 2010 - 2011 / · Development of Professional Standards and Guidelines and online educational resources by PSA.
· PPI: Support for the Provision of Dose Administration Aids / Consultation about the evaluation of the 4CPA DAA/PMP Programme / · Broad stakeholder input under 4CPA DAA/PMP evaluation. / September 2007 – June 2009 / · Inclusion of a DAA component in the 5CPA.
· PPI: Staged supply support allowance / Consultation about the 4CPA review of Staged Supply regarding implications for community pharmacies in the administration of Staged Supply of PBS medicines. / · AMA
· CHF
· State and territory health departments
· SHPA
· ANCD
· diverse range of other stakeholders / February 2010 – 2011 / · Inclusion of Staged Supply component in 5CPA.
Consultation on activities to support the roll-out of the PPI Programme under 5CPA / · PSA with Expert Reference Group involvement. / September 2010 – 2011 / · Development of professional Standards and Guidelines and online educational resources by PSA.
· PPI: Funding to support the Accreditation System and roll-out of Additional Programmes to Support Patient Services / Development of a Community Pharmacy Service Charter / · ACSA
· AHPA
· APESMA
· AACP
· AGPN
· AHPRA
· AHRC
· AMA
· ANF
· ASMI
· Carers Australia
· CHF
· Council of the Ageing
· NACCHO
· NAPSA
· NEDA
· NPS
· NRHA
· PSA
· PBA
· SHPA
· ACSQHC
· Guild / December 2010 – June 2011 / · Convened a workshop in December 2010 to discuss how to tailor the Australian Charter of Healthcare Rights to be suitable for a community pharmacy setting.
· Draft concepts for the Community Pharmacy Charter were developed and distributed for wider consultation and comment.
· The Community Pharmacy Service Charter was finalised and implemented in June 2011.
Research and Development / Workshop to inform 5CPA research priorities and identify a list of potential projects for research focus under the 5CPA / Approximately 175 participants attended a workshop representing a wide range of stakeholders that included:
professional and industry organisations, government, peak bodies and consumers.
The Advisory Panels comprise representatives from the following organisations:
· PSA
· CHF
· ASMI
· SHPA
· AACP
· AMA
· RACGP
· Illuminate Health Consulting
· NRHA
· Health Consumers of Rural & Remote Australia
· PBA
· The George Institute for Global Health
· NMHCCF / March 2010 and April 2011 / A number of research priority areas were recommended, including six that were subsequently funded under the 5CPA programme:
· Mental Health
· Professional Integration (Collaboration)
· Rural
· Health Literacy
· Consumer Needs
· Chronic Illness
The Rural project has subsequently been discontinued.
Establishment of Advisory Panels to oversee the research projects.
Advisory panels select tenders and provide advice and guidance on the individual research projects.
Inclusion of a further Research and Development project on HMR Patient Eligibility / · Guild / March 2013 - October 2013 / · Commencement in October 2013 of HMR Patient Eligibility project.
Supply and PBS claiming from a medication chart in Residential Aged Care Facilities / Review of the Existing Supply
Arrangements of PBS Medicines
in Residential Aged Care
Facilities and Private Hospitals under 4CPA / · Aged care sector
· Private hospitals
· Medical practitioners
· Nurses
· Pharmacists
Residents and patients / September 2009 / · Inclusion of ‘Medication Charts’ initiative in 5CPA.
· Informing policy parameters of initiative.
Initiative Development Meetings / · Guild
· DHS
· OACQC
· ACSQHC / August 2010 – October 2012 / · Development of a public consultation paper.
· Identification and resolution of policy issues in relation to programme design and implementation.
· Agreement on elements of the programme that required broader consultation.
Supply and PBS claiming from a medication chart in Residential Aged Care Facilities / Draft content of consultation paper for comment / · PRG
· AMA / November – December 2010 / Changes were made to the draft public consultation papers as a result of PRG advice including:
· increased emphasis on the reduced administrative burden for the pharmacist;
· ensured consistent use of the term “prescriber”, as opposed to medical practitioner or doctor;
· included further information on the link with QUM policy and the Authority medicines process.
Call for responses on parameters of the initiative through the release of a consultation paper / · PRG
· Targeted aged care stakeholders
· Broad range of pharmacy and prescribing industry stakeholders
· State and territory health authorities
· The general public / March 2011 –
April 2011 / · Responses informed legislative amendments currently before parliament.
· Highlighted the importance of safety and quality use of medicines requirements which have resulted in the Department engaging the ACSQHC to develop the National Residential Medication chart.
· Informed issues to be address in relation to implementation and change management activities.
Site visits to inform policy and implementation issues / · Aged care facilities
· Public and private hospitals
· Community pharmacies
· Medication packaging companies / November 2010 – June 2011 / · Inform legislative amendments to the National Health Act 1953, identify policy issues and potential change management issues.
Discussions with the AMA to identify issues for prescribers / · AMA / November 2010, June 2011, January 2012 and
April 2012 / · Resolved the issue about how ‘repeat’ medication orders will be dealt with on the chart